The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Kennedy Jr., has severely restricted the use of the NovavaxCOVID-19 vaccine. The vaccine will now only be available to ...

Secretary Robert F. Kennedy Jr., who leads the Department of Health and Human Services, will soon announce the changes to the ...

New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had ...

由于每年需要分别接种1剂流感疫苗和新冠疫苗，这种接种程序的不便利导致美国两款疫苗的接种率日益下滑。为了解决这一难题、稳住新冠疫苗需求下降导致业绩持续滑坡的风险，mRNA疫苗巨头Moderna公司于昨日在美国医学会杂志（JAMA）上发表了其研发的新冠&流感病毒mRNA联合疫苗的III期临床结果。

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...

U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...